GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 4251 - 4300 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
6WHT Q00960 GluN1b-GluN2B NMDA receptor in active conformation at 4.4 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WI0 P35439 GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WI0 Q00960 GluN1b-GluN2B NMDA receptor in complex with GluN1 antagonist L689,560, class 2 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHS P35439 GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6WHS Q00960 GluN1b-GluN2B NMDA receptor in non-active 1 conformation at 3.95 angstrom resolution Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B
6MMJ P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMJ Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMM Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMW P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMW Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMB P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMB Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMT P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMT Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMU P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMU Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MM9 P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MM9 Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMG Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMK Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMS P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMS Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMA Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMI P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Splayed-Open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMI Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Splayed-Open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MML Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMX P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMX Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the 'Extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMH Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMP Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar EDTA, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMR Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar EDTA, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMN Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the '2-Knuckle-Symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 8.0 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
6MMV Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* Extracellular Domain in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4 Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A
4GPA P19493 High resolution structure of the GluA4 N-terminal domain (NTD) Glutamate receptor 4
6NJM P19492 Architecture and subunit arrangement of native AMPA receptors Glutamate receptor 3, Glutamate receptor 2, A'-C' auxiliary proteins, Voltage-dependent calcium channel gamma-2 subunit, 5B2 Fab Light Chain, 5B2 Fab Heavy Chain, 15F1 Fab light chain, 15F1 Fab heavy chain
6NJM P19491 Architecture and subunit arrangement of native AMPA receptors Glutamate receptor 3, Glutamate receptor 2, A'-C' auxiliary proteins, Voltage-dependent calcium channel gamma-2 subunit, 5B2 Fab Light Chain, 5B2 Fab Heavy Chain, 15F1 Fab light chain, 15F1 Fab heavy chain
6NJM 6NJM Architecture and subunit arrangement of native AMPA receptors Glutamate receptor 3, Glutamate receptor 2, A'-C' auxiliary proteins, Voltage-dependent calcium channel gamma-2 subunit, 5B2 Fab Light Chain, 5B2 Fab Heavy Chain, 15F1 Fab light chain, 15F1 Fab heavy chain
6NJM Q71RJ2 Architecture and subunit arrangement of native AMPA receptors Glutamate receptor 3, Glutamate receptor 2, A'-C' auxiliary proteins, Voltage-dependent calcium channel gamma-2 subunit, 5B2 Fab Light Chain, 5B2 Fab Heavy Chain, 15F1 Fab light chain, 15F1 Fab heavy chain
3O21 P19492 High resolution structure of GluA3 N-terminal domain (NTD) Glutamate receptor 3
5VHW P19491 GluA2-0xGSG1L bound to ZK Glutamate receptor 2,Germ cell-specific gene 1-like protein

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024